Peak Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
17,035
-838
-5% -$96.7K 0.36% 56
2025
Q4
$1.88M Sell
17,873
-372
-2% -$34.9K 0.32% 59
2025
Q3
$1.53M Sell
18,245
-825
-4% -$68K 0.27% 63
2025
Q2
$1.51M Buy
19,070
+743
+4% +$59.1K 0.28% 66
2025
Q1
$1.65M Buy
18,327
+695
+4% +$64.9K 0.31% 60
2024
Q4
$1.75M Buy
17,632
+590
+3% +$60.8K 0.32% 58
2024
Q3
$1.94M Sell
17,042
-867
-5% -$103K 0.36% 56
2024
Q2
$2.22M Sell
17,909
-1,021
-5% -$132K 0.43% 46
2024
Q1
$2.5M Sell
18,930
-1,366
-7% -$168K 0.49% 45
2023
Q4
$2.21M Buy
20,296
+128
+0.6% +$13.3K 0.49% 48
2023
Q3
$2.08M Buy
20,168
+275
+1% +$29.6K 0.5% 48
2023
Q2
$2.3M Buy
19,893
+94
+0.5% +$10.7K 0.53% 46
2023
Q1
$2.11M Sell
19,799
-93
-0.5% -$10K 0.51% 46
2022
Q4
$2.21M Sell
19,892
-30
-0.2% -$3.07K 0.58% 40
2022
Q3
$1.72M Buy
19,922
+135
+0.7% +$12.1K 0.49% 44
2022
Q2
$1.8M Sell
19,787
-230
-1% -$20.4K 0.49% 45
2022
Q1
$1.64M Buy
20,017
+1,113
+6% +$87.8K 0.38% 51
2021
Q4
$1.45M Buy
18,904
+250
+1% +$19.9K 0.33% 55
2021
Q3
$1.4M Buy
18,654
+48
+0.3% +$3.65K 0.35% 53
2021
Q2
$1.45M Sell
18,606
-1,267
-6% -$94.2K 0.36% 49
2021
Q1
$1.46M Buy
19,873
+304
+2% +$22.4K 0.35% 51
2020
Q4
$1.53M Buy
19,569
+154
+0.8% +$11.8K 0.4% 49
2020
Q3
$1.54M Sell
19,415
-145
-0.7% -$11.4K 0.46% 47
2020
Q2
$1.44M Buy
19,560
+4,234
+28% +$319K 0.46% 43
2020
Q1
$1.13M Sell
15,326
-1,612
-10% -$127K 0.43% 45
2019
Q4
$1.47M Buy
16,938
+582
+4% +$47.8K 0.45% 43
2019
Q3
$1.31M Sell
16,356
-135
-0.8% -$10.8K 0.43% 46
2019
Q2
$1.32M Sell
16,491
-413
-2% -$31.6K 0.43% 48
2019
Q1
$1.34M Sell
16,904
-1,560
-8% -$117K 0.46% 46
2018
Q4
$1.35M Sell
18,464
-1,586
-8% -$112K 0.51% 45
2018
Q3
$1.36M Sell
20,050
-225
-1% -$14.3K 0.46% 44
2018
Q2
$1.17M Sell
20,275
-58
-0.3% -$3.27K 0.43% 44
2018
Q1
$1.06M Buy
20,333
+1,621
+9% +$87.5K 0.39% 46
2017
Q4
$1M Buy
18,712
+2,433
+15% +$135K 0.37% 49
2017
Q3
$995K Sell
16,279
-4
-0% -$243 0.36% 54
2017
Q2
$996K Buy
16,283
+1,134
+7% +$69K 0.37% 52
2017
Q1
$918K Sell
15,149
-753
-5% -$45.7K 0.35% 57
2016
Q4
$893K Sell
15,902
-262
-2% -$15.3K 0.36% 57
2016
Q3
$963K Hold
16,164
0.4% 56
2016
Q2
$889K Hold
16,164
0.39% 54
2016
Q1
$816K Buy
16,164
+262
+2% +$12.8K 0.39% 51
2015
Q4
$801K Buy
15,902
+2,022
+15% +$102K 0.39% 43
2015
Q3
$654K Buy
13,880
+796
+6% +$42.3K 0.35% 49
2015
Q2
$711K Sell
13,084
-4,686
-26% -$263K 0.37% 50
2015
Q1
$975K Buy
17,770
+239
+1% +$13.5K 0.48% 40
2014
Q4
$950K Buy
+17,531
New +$977K 0.5% 42

Other funds holding MRK

Peak Asset Management's MRK Position: Q1 2026 in Review

Peak Asset Management reduced its Merck (MRK) stake by 4.7% in Q1 2026, selling an estimated $96.7K and leaving 17,035 shares worth $2.05M. The position accounts for 0.36% of the portfolio, ranked #56.

Peak Asset Management first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.5M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Peak Asset Management held 17,035 shares of Merck worth $2.05M as of Q1 2026.
  • Peak Asset Management sold 838 Merck shares in Q1 2026, an estimated $96.7K.
  • Merck made up 0.36% of Peak Asset Management's portfolio in Q1 2026, its #56 holding.
  • Peak Asset Management first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
  • Peak Asset Management's Merck position peaked at $2.5M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Peak Asset Management's 13F filing for Q1 2026, filed 15 May 2026.